This application is a U.S. patent application filed under 35 U.S.C. 371, based on PCT International Application No. PCT/GB00/02017, filed Jun. 5, 2000, which claims priority to Great Britain Patent Application Nos. 9913047.8 and 9916283.6, filed Jun. 5, 1999 and Jul. 13, 1999, respectively, both of which are hereby incorporated by reference in their entirety.
This invention relates to a novel form of medicament delivery system and to novel methods of treatment.
In particular the invention provides a medicament delivery device, such as an inhaler, which is adapted to be moisture resistant and/or provides improved air flow through the device.
It is well established that delivery devices adapted for the delivery of dry powder medicaments suffer from the problem of contact with moisture. Such problems are particularly when hygroscopic medicaments are used or when climatic conditions give rise to high humidity. Medicament inhalers are known to suffer from such and moisture contamination of dry powder inhalers has long been held to be undesirable since the dry powder medicament may become clogged, creating problems in delivering correct dosages of medicament. Furthermore, some inhaled medicaments are themselves inherently moisture sensitive. Therefore, there has long been a desire to provide a dry powder inhaler that is resistant to moisture, that is, one that protects a medicament reservoir from moisture contamination either from the environment or from exhalation by a patient using the device and various attempts have been made to mitigate the problem.
Most attempts which have been made aim to reduce the moisture which comes into contact with a medicament, such attempts generally comprise the use of an additional chamber containing a desiccant.
International Patent Application No WO 98/41261 describes an inhalation device which includes a chamber for containing a desiccant, e.g. silica gel. Whilst the use of a desiccant gel does remove some moisture, the system is disadvantageous in that, inter alia, the leak paths are too great for the available desiccant to cope with and therefore the desiccant is only effective for a few hours, whereas there is a need for moisture resistance if at least a few months.
Similarly, International Patent Application No WO 96/08284 describes an inhaler system provided with a reservoir wherein the closed end of the reservoir is also provided with a desiccant cartridge.
International Patent Application No WO 95/32752 also describes a medicament chamber included in an inhalation apparatus and provided with a container containing a desiccant.
European Patent Application No. EP0520 440, Ambrosio et al, describes a dry powder inhaler which includes a moisture resistant barrier in the form of a flap which is designed to prevent exhaled air from a patient contaminating the medicament held in the reservoir.
U.S. Pat. No. 3,854,626, Krechmar et al, describes a pill dispensing system which comprises a moveable mechanism which prevents the ingress of moisture whilst permitting the dispensing of one or more pills.
We have now developed a medicament delivery device, e.g. a dry powder inhaler, which is able to provide a moisture proof barrier without the necessity of a desiccant.
Therefore, according to the invention we provide a medicament delivery device which comprises a medicament reservoir, a medicament delivery passage and a metering member adapted to transfer a measured dose of medicament from the medicament reservoir to the delivery passage characterised in that the device is provided with a moisture proof barrier.
The moisture proof barrier is preferentially a physical barrier as opposed to a chemical barrier, e.g. a desiccant, although it is within the scope of the present invention that a desiccant may be included in addition to the moisture proof barrier if desirable.
In a preferred embodiment the moisture proof barrier is positioned so as to prevent the ingress of moisture into the medicament reservoir, so that moisture is prevented from coming into contact with the medicament. In an especially preferred embodiment of the delivery device of the invention, the moisture proof barrier is a moisture proof sealing means.
In a preferred embodiment, the sealing means of the delivery device will operate by the delivery device being adapted to move from an inoperable position, in which the medicament reservoir is sealed, to an operative position, in which the seal is reversibly broken so that measurement and/or delivery of a dose of medicament may take place. The sealing means will generally comprise a resilient sealing member positioned at the end of the reservoir adjacent the metering member. Furthermore, the metering member is preferentially biased towards the resilient sealing member to improve the seal provided. Preferably the resilient sealing member is in a fixed position whilst the metering member moves from an inoperable to an operable position and thus from a sealing to a non-sealing position.
The resilient sealing member preferably comprises a cover adapted to fit the base of the medicament reservoir, the sealing member being provided with an aperture to permit transmission of the medicament. The resilient sealing member may comprise any conventionally known material, for example a natural or synthetic rubber, a silicon or a PTFE material, although other similar materials can be contemplated within the scope of this invention.
The moisture proof barrier of the invention may be applied to any conventionally known medicament delivery system. However, in a preferred embodiment, the medicament delivery device is an inhaler. Whilst the moisture proof barrier may be applied to any conventionally known inhaler, it is an especially preferred aspect of the invention for the inhaler to be a dry powder inhaler (DPI). DPI's are known which operate with predetermined doses of medicament, for example, the medicament may be coned in a gelatin capsule which is ruptured to release the medicament. However, a preferred inhaler of the invention is a DPI which comprises a medicament reservoir a metering member which is adapted to measure a selected amount of medicament for inhalation. Thus, in an especially preferred embodiment the metering member is rotatable from an operable to an inoperable position. The metering member may comprise a dispensing member and a moisture resistant member, e.g. a moisture resistant sleeve. In such an embodiment the moisture resistant member is provided with one or more measure chambers adapted to measure a predetermined dosage of medicament. Thus, in the operable position, the position of measuring chamber of the metering member corresponds with the aperture in the resilient sealing member so that medicament enters the measuring chamber. The moisture resistant member may then be rotated so that the reservoir is sealed again by the wall of the moisture resistant member. At the same time the medicament is transferred from the measuring chamber of the moisture resistant sleeve to the dispensing chamber of the dispensing member.
An example of a preferred DPI is CLICKHALER, produced by Innovata Biomed in the UK. Such a device is described in European Patent No 0 539 469. Thus, the metering member may be a frusto conical member such as described in European Patent No 0 539 469.
Therefore, the metering member may comprise a frusto conical dispensing member with a corresponding moisture resistant sleeve, such that the sleeve overlies the dispensing member. Thus, the measuring chamber may comprise outer side walls which are provided by an aperture in the wall of the moisture resistant sleeve and the base of the measuring chamber may be provided by the frusto conical wall of the dispensing member. Preferably the moisture resistant sleeve is provided with a plurality of apertures and thereby a plurality of measuring chambers.
The use of the frusto-conical shape in the wall of the metering member containing the measuring chamber allows a good seal to be obtained between the metering member and a seat against which the frusto-conical wall mates.
Therefore, the frusto conical metering member may itself comprise a combination of a frusto conical dispensing member and a frusto conical moisture resist sleeve which forms a snug fit over the dispensing member. The moisture resistant sleeve may itself be moveable eg rotatable, from a sealing to a non-sealing position as herein before described and vice verse. Such a moisture resistant sleeve may comprise any conventionally known material but is preferentially a plastics material, e.g. the same material as the metering member.
The dispensing member and the moisture resistant sleeve can, preferentially, be adapted so as to act together as a medicament measuring/dispensing member. The preferred metering member comprises a dispensing member provided with one or more dispensing cups and a moisture resistant sleeve provided with one or more apertures. Preferably the dispensing member comprises a plurality of dispensing cups and the sleeve comprises a plurality of apertures. It is especially preferred that the dispensing member comprises an equivalent number of dispensing cups to apertures in the sleeve.
We have especially found that if the moisture resistant sleeve comprises a frusto hemispherical cone, then an improved seal is achieved between the medicament reservoir and the sleeve. When a frusto hemispherical cone sleeve is used, the arcuate base of the reservoir is able to make more uniform contact with the curved surface of the cone and therefore an improved seal is achieved. Thus, it is especially preferred that the outer walls of the cone which are hemispherical. Furthermore, the inner walls of the cone are preferably contoured to form a good mate with the frusto conical dispensing member.
Thus, in operation, the metering member may be moved to a first position in which the medicament is transferred to a first measuring chamber in the moisture resistant sleeve, the device is then moved to a second position in which medicament is transferred from the measuring chamber to a dispensing cup in the dispensing member and then to a third position where medicament is delivered to the delivery passage.
The dispensing member may be a conventionally known member such as a frusto conical member described herein and in EP 0 539 469. However, we have also found the use of a moisture resistant sleeve permits a dispensing chamber to be provided with an air inlet, e.g. an air duct. Previously, the use of an air inlet was felt to be undesirable since it might effect the accuracy of the measurement of the medicament dose. However, by use of a system wherein the medicament is first transferred to a measuring chamber and then subsequently to a dispensing cup, the cup in the dispensing member may be provided with an air inlet without any loss in accuracy of the dosage delivered. Furthermore, improved air flow provides greater likelihood of complete emptying of the dispensing cup and thereby provide an inhaler with improved performance. Clearly, an inhaler with such improved performance is advantageous per se, regardless of whether such an inhaler is moisture resistant.
Thus according to an alternative feature of the invention we provide a dry powder inhaler which comprises a medicament reservoir, an inhalation passage for the delivery of the medicament and a metering member adapted to transfer a measured dose of medicament from the medicament reservoir to the inhalation passage characterised in that the metering member comprises a measuring member adapted to measure a pre-defined dosage of medicament and moveable from a measuring to a non-measuring position; and a dispensing member adapted to receive the measured dosage of medicament from the measuring member and to deliver the medicament to the inhalation passage, the dispensing member being moveable from a medicament receiving position to a medicament delivering position.
In the preferred embodiment the dispensing member is provided with one or more medicament dispensing cups, said cups being provided with a duct so as to provide a flow of air through the cup and into the inhalation passage upon operation of the device.
By the term dry powder we mean a medicament in finely divided form.
A variety of medicaments may be administered by using the inhaler of the invention, optionally with a conventionally known pharmaceutically acceptable adjuvant, diluent or carrier. Such medicaments are generally antibiotics, bronchodilators or other anti-asthma drugs. Such medicaments include, but are not limited to β2-agonists, e.g. fenoterol, formoterol, pirbuterol, reproterol, rimiterol, salbutamol, salmeterol and terbutaline; non-selective beta-stimulants such as isoprenaline; xanthine bronchodilators, e.g. theophylline, aminophylline and choline theophyllinate; anticholinergics, e.g. ipratropium bromide; mast cell stabilisers, e.g. sodium cromoglycate and ketotifen; bronchial anti-inflammatory agents, e.g. nedocromil sodium; and steroids, e.g. beclomethasone dipropionate, fluticasone, budesonide and flunisolide; and combinations thereof.
Specific combinations of medicaments which may be mentioned include combinations of steroids, such as, beclomethasone dipropionate, fluticasone, budesonide and flunisolide; and combinations of to β2-agonists, such as, formoterol and salmeterol. It is also within the scope of this invention to include combinations of one or more of the aforementioned steroids with one or more of the aforementioned β2-agonists.
The inhaler of the invention is especially suitable for use in the treatment or alleviation of respiratory disorders. Thus according to the invention we also provide a method of administering a dry powder inhalation medicament using an inhaler as hereinbefore described.
We further provide a method of treatment of a patient with a respiratory disorder which comprises the administration of a combination of medicaments using an inhaler as hereinbefore described.
The invention will now be described by way of example only and with reference to the accompanying drawings in which:
a–f are schematic representations of the sealing and measuring mechanism.
a–b are cross-sectional views of a moisture resistant sleeve comprising a frusto herispherical cone.
With reference to
The recess (6) is essentially frusto conical in shape to enable it to provide a seal for the metering member (4). The metering member (4) comprises a frusto conical moisture resistant sleeve (9) which forms a snug fit between recess (6) and a dispensing member (10). The dispensing member (10) is also provided with a back plate (11).
The moisture resistant sleeve (9) abuts at the resilient seal (9a) to form a moisture resistant seal.
The moisture resistant sleeve (9) is also provided with a plurality of measuring chambers which comprise apertures (12) dimensioned to measure a predetermined amount of medicament and to fit over cups (13) in the dispensing member (10). In a preferred embodiment, each of the cups (13) are also provided with a duct (14). The medicament reservoir (2) is also provided with a moisture resistant, eg foil, cover (15) at it's end (16) distal from the metering member (4).
With reference to
b the metering device is in a measuring position,
c the metering device is in a seal transitory position,
d the metering device is in a medicament transfer position,
e the metering device is in a medicament delivery position; and
f the metering device is returned to the closed position.
In
In
In
In
In
With reference to
A variety of mechanisms may be used for the operation of the inhaler. One preferred mechanism is for movement from the closed to the measuring position to be achieved by removal of a month piece which is operably linked to the moisture resistor. Movement from the measuring position to the transitory position would use a mechanism similar to that described in EP 0 539 469, e.g. by depressing the button half way. Movement to the transfer position being achieved by further depressing the button, and then depression completely, moving the metering cone and the moisture resistor to the delivery position.
Number | Date | Country | Kind |
---|---|---|---|
9913047.8 | Jun 1999 | GB | national |
9916283.6 | Jul 1999 | GB | national |
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/GB00/02017 | 6/5/2000 | WO | 00 | 5/20/2002 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO00/74754 | 12/14/2000 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
1858735 | Goodsell | May 1932 | A |
2587215 | Priestly | Feb 1952 | A |
3008609 | Sessions | Nov 1961 | A |
3439823 | Morane | Apr 1969 | A |
3798054 | Kawata et al. | Mar 1974 | A |
3854626 | Krechmar | Dec 1974 | A |
3874381 | Baum | Apr 1975 | A |
3876269 | Fisher et al. | Apr 1975 | A |
4047635 | Bennett, Jr. | Sep 1977 | A |
4114615 | Wetterlin | Sep 1978 | A |
4174034 | Hoo | Nov 1979 | A |
4200099 | Guenzel et al. | Apr 1980 | A |
4274403 | Struve | Jun 1981 | A |
4524769 | Wetterlin | Jun 1985 | A |
4534343 | Nowacki et al. | Aug 1985 | A |
4570630 | Elliott et al. | Feb 1986 | A |
4604847 | Moulding, Jr. et al. | Aug 1986 | A |
4624442 | Duffy et al. | Nov 1986 | A |
4627432 | Newell et al. | Dec 1986 | A |
4635829 | Brittingham, Jr. | Jan 1987 | A |
4668218 | Virtanen | May 1987 | A |
4811731 | Newell et al. | Mar 1989 | A |
4860740 | Kirk et al. | Aug 1989 | A |
4882210 | Romberg et al. | Nov 1989 | A |
4895719 | Radhakrishnan et al. | Jan 1990 | A |
4907583 | Wetterlin et al. | Mar 1990 | A |
4934358 | Nilsson et al. | Jun 1990 | A |
4950365 | Evans | Aug 1990 | A |
5002048 | Makiej, Jr. | Mar 1991 | A |
5007419 | Weinstein et al. | Apr 1991 | A |
5042472 | Bunin | Aug 1991 | A |
5053237 | Hendricks et al. | Oct 1991 | A |
5064083 | Alexander et al. | Nov 1991 | A |
5067491 | Taylor, II et al. | Nov 1991 | A |
5113855 | Newhouse | May 1992 | A |
5152422 | Springer | Oct 1992 | A |
5154326 | Chang et al. | Oct 1992 | A |
5161524 | Evans | Nov 1992 | A |
5169029 | Behar et al. | Dec 1992 | A |
5192528 | Radhakrishnan et al. | Mar 1993 | A |
5201308 | Newhouse | Apr 1993 | A |
5207217 | Cocozza et al. | May 1993 | A |
5208226 | Palmer | May 1993 | A |
5253782 | Gates et al. | Oct 1993 | A |
5263475 | Altermatt et al. | Nov 1993 | A |
5295479 | Lankinen | Mar 1994 | A |
5301666 | Lerk et al. | Apr 1994 | A |
5320714 | Brendel | Jun 1994 | A |
5347999 | Poss et al. | Sep 1994 | A |
5351683 | Chiesi et al. | Oct 1994 | A |
5394868 | Ambrosio et al. | Mar 1995 | A |
5409132 | Kooijmans et al. | Apr 1995 | A |
5411175 | Armstrong et al. | May 1995 | A |
5415162 | Casper et al. | May 1995 | A |
5435301 | Herold et al. | Jul 1995 | A |
5437267 | Weinstein et al. | Aug 1995 | A |
5437270 | Braithwaite | Aug 1995 | A |
5447151 | Bruna et al. | Sep 1995 | A |
5450160 | Tianello et al. | Sep 1995 | A |
5458135 | Patton et al. | Oct 1995 | A |
5485939 | Tucker | Jan 1996 | A |
5503144 | Bacon | Apr 1996 | A |
5520166 | Ritson et al. | May 1996 | A |
5524613 | Haber et al. | Jun 1996 | A |
5551597 | Lambelet, Jr. et al. | Sep 1996 | A |
5562231 | Lambelet, Jr. et al. | Oct 1996 | A |
5562918 | Stimpson | Oct 1996 | A |
5575280 | Gupte et al. | Nov 1996 | A |
5617845 | Poss et al. | Apr 1997 | A |
5622166 | Eisele et al. | Apr 1997 | A |
5653227 | Barnes et al. | Aug 1997 | A |
5657748 | Braithwaite | Aug 1997 | A |
5657794 | Briner et al. | Aug 1997 | A |
5664557 | Makiej, Jr. | Sep 1997 | A |
5664697 | Lambelet, Jr. et al. | Sep 1997 | A |
5676130 | Gupte et al. | Oct 1997 | A |
5678538 | Drought | Oct 1997 | A |
D389570 | Savolainen | Jan 1998 | S |
5740792 | Ashley et al. | Apr 1998 | A |
5740794 | Smith et al. | Apr 1998 | A |
5775536 | Lambelet, Jr. et al. | Jul 1998 | A |
5778873 | Braithwaite | Jul 1998 | A |
5785049 | Smith et al. | Jul 1998 | A |
5799821 | Lambelet, Jr. et al. | Sep 1998 | A |
5857457 | Hyppölä | Jan 1999 | A |
5875776 | Vaghefi | Mar 1999 | A |
5881719 | Gottenauer et al. | Mar 1999 | A |
5896855 | Hobbs et al. | Apr 1999 | A |
5904139 | Hauser | May 1999 | A |
5921237 | Eisele et al. | Jul 1999 | A |
5924417 | Braithwaite | Jul 1999 | A |
5941241 | Weinstein et al. | Aug 1999 | A |
5944660 | Kimball et al. | Aug 1999 | A |
5955439 | Green | Sep 1999 | A |
5981549 | Viner | Nov 1999 | A |
5996577 | Ohki et al. | Dec 1999 | A |
6006747 | Eisele et al. | Dec 1999 | A |
6035463 | Pawelzik et al. | Mar 2000 | A |
6065471 | Schaeffer et al. | May 2000 | A |
6065472 | Anderson et al. | May 2000 | A |
6089227 | Nilsson | Jul 2000 | A |
6116238 | Jackson et al. | Sep 2000 | A |
6116239 | Volgyesi | Sep 2000 | A |
6119688 | Whaley et al. | Sep 2000 | A |
6125844 | Samiotes | Oct 2000 | A |
6158675 | Ogi | Dec 2000 | A |
6196218 | Voges | Mar 2001 | B1 |
6220243 | Schaeffer et al. | Apr 2001 | B1 |
6234167 | Cox et al. | May 2001 | B1 |
6240918 | Ambrosio et al. | Jun 2001 | B1 |
6254854 | Edwards et al. | Jul 2001 | B1 |
6273085 | Eisele et al. | Aug 2001 | B1 |
6321747 | Dmitrovic et al. | Nov 2001 | B1 |
6324428 | Weinberg et al. | Nov 2001 | B1 |
6325241 | Garde et al. | Dec 2001 | B1 |
6328034 | Eisele et al. | Dec 2001 | B1 |
6347629 | Braithwaite | Feb 2002 | B1 |
6418926 | Chawla | Jul 2002 | B1 |
6443146 | Voges | Sep 2002 | B1 |
6484718 | Schaeffer et al. | Nov 2002 | B1 |
6523536 | Fugelsang et al. | Feb 2003 | B2 |
6543443 | Klimowicz et al. | Apr 2003 | B1 |
6553987 | Davies | Apr 2003 | B1 |
6557550 | Clarke | May 2003 | B1 |
6557552 | Cox et al. | May 2003 | B1 |
6601729 | Papp | Aug 2003 | B1 |
6675839 | Braithwaite | Jan 2004 | B1 |
6698425 | Widerström | Mar 2004 | B1 |
6810873 | Haikarainen et al. | Nov 2004 | B1 |
6810874 | Koskela et al. | Nov 2004 | B1 |
6845772 | Braithwaite et al. | Jan 2005 | B2 |
6926003 | Seppälä | Aug 2005 | B2 |
20030075172 | Johnson et al. | Apr 2003 | A1 |
20030116157 | Braithwaite et al. | Jun 2003 | A1 |
20030136406 | Seppala | Jul 2003 | A1 |
20040011357 | Braithwaite | Jan 2004 | A1 |
20040101482 | Sanders | May 2004 | A1 |
20040236282 | Braithwaite | Nov 2004 | A1 |
20040251318 | Braithwaite | Dec 2004 | A1 |
20050121023 | Braithwaite | Jun 2005 | A1 |
Number | Date | Country |
---|---|---|
14 98 398 | Jan 1969 | DE |
23 46 730 | Apr 1975 | DE |
32 43 731 | May 1984 | DE |
195 30 240 | Feb 1997 | DE |
197 57 207 | Jun 1999 | DE |
0 045 522 | Feb 1982 | EP |
0 079 478 | May 1983 | EP |
0 166 294 | Oct 1989 | EP |
0 469 814 | Feb 1992 | EP |
0 514 085 | Nov 1992 | EP |
0 520 440 | Dec 1992 | EP |
0 372 777 | Jan 1993 | EP |
0 539 469 | May 1993 | EP |
0 424 790 | Aug 1993 | EP |
0 626 689 | Nov 1994 | EP |
0 548 605 | Jan 1995 | EP |
0 448 204 | Apr 1995 | EP |
0 659 432 | Jun 1995 | EP |
0 663 815 | Jul 1995 | EP |
2 516 387 | May 1983 | FR |
2 584 604 | Jan 1987 | FR |
2 662 936 | Dec 1991 | FR |
2 753 791 | Mar 1998 | FR |
3908 | Mar 1911 | GB |
1 242 211 | Aug 1971 | GB |
1 573 551 | Aug 1980 | GB |
2 041 763 | Sep 1980 | GB |
2 165 159 | Apr 1986 | GB |
2 178 965 | Feb 1987 | GB |
2 235 753 | Mar 1991 | GB |
2 248 400 | Apr 1992 | GB |
WO 9007351 | Jul 1990 | WO |
WO 9104011 | Apr 1991 | WO |
WO 9111173 | Aug 1991 | WO |
WO 9111495 | Aug 1991 | WO |
WO 9114422 | Oct 1991 | WO |
WO 9200771 | Jan 1992 | WO |
WO 9203175 | Mar 1992 | WO |
WO 9204928 | Apr 1992 | WO |
WO 9209322 | Jun 1992 | WO |
WO 9218188 | Oct 1992 | WO |
WO 9300951 | Jan 1993 | WO |
WO 9311746 | Jun 1993 | WO |
WO 9316748 | Sep 1993 | WO |
WO 9500128 | Jan 1995 | WO |
WO 951577 | Jun 1995 | WO |
WO 9700399 | Jan 1997 | WO |
WO 9826828 | Jun 1998 | WO |
WO9830262 | Jul 1998 | WO |
WO 9831352 | Jul 1998 | WO |
WO 9912597 | Mar 1999 | WO |
WO 9913930 | Mar 1999 | WO |
WO 9926676 | Jun 1999 | WO |
WO 0012163 | Mar 2000 | WO |
WO 0045878 | Aug 2000 | WO |
WO 0064519 | Nov 2000 | WO |
WO 0117595 | Mar 2001 | WO |
WO 0151030 | Jul 2001 | WO |
WO 0160341 | Aug 2001 | WO |
WO 0187378 | Nov 2001 | WO |